Company news

Alebund Pharmaceuticals (jiangsu) Limited Class H (HKEX:9637) news

Alebund Pharmaceuticals (jiangsu) Limited Class H news releases on 6ix. Latest, Aug 7, 2026: Alebund's AP301 NDA Accepted for Review by China's NMPA

View Alebund Pharmaceuticals (jiangsu) Limited Class H →

Press releases & updates

Alebund's AP301 NDA Accepted for Review by China's NMPA

August 7, 2026

ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS

June 26, 2026

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

June 25, 2026

Documents on Display

June 17, 2026

PHIP (1st submission)

June 14, 2026